- Home
- TAOP vs CRIS Comparison
TAOP vs CRIS Comparison
Compare TAOP & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TAOP | CRIS |
|---|---|---|
| Founded | 1993 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2M | 12.9M |
| IPO Year | 2012 | 2000 |
Fundamental Metrics
Financial Performance| Metric | TAOP | CRIS |
|---|---|---|
| Price | $1.41 | $1.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.50 |
| AVG Volume (30 Days) | 8.1K | ★ 172.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.21 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,898,000.00 |
| Revenue This Year | N/A | $6.13 |
| Revenue Next Year | N/A | $7.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $0.14 | $0.77 |
| 52 Week High | $8.78 | $3.18 |
Technical Indicators
Market Signals| Indicator | TAOP | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 47.89 | 45.11 |
| Support Level | $1.33 | $0.80 |
| Resistance Level | $1.59 | $1.04 |
| Average True Range (ATR) | 0.10 | 0.08 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 48.61 | 18.60 |
Price Performance
Historical ComparisonAbout TAOP Taoping Inc.
Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.